Cargando…
Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: A qualitative analysis
PURPOSE: A utologous stem cell transplant (ASCT) remains a standard of care among older adults (aged ≥65) with multiple myeloma (MM). However, heterogeneity in the eligibility and utilization of ASCT remains. We identified decision-making factors that influence ASCT eligibility and utilization among...
Autores principales: | Mian, Owais, Puts, Martine, McCurdy, Arleigh, Wildes, Tanya M., Fiala, Mark A., Kang, Matthew, Salib, Mary, Alibhai, Shabbir, Mian, Hira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911655/ https://www.ncbi.nlm.nih.gov/pubmed/36776355 http://dx.doi.org/10.3389/fonc.2022.974038 |
Ejemplares similares
-
Real-world results of autologous stem cell transplantation in newly diagnosed multiple myeloma: a report from the Canadian Myeloma Research Group database
por: Côté, Julie, et al.
Publicado: (2023) -
Symptom burden in transplant-ineligible patients with newly diagnosed multiple myeloma: a population-based cohort study
por: Mian, Hira S., et al.
Publicado: (2020) -
Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study
por: McCurdy, Arleigh, et al.
Publicado: (2023) -
Real‐world data on lenalidomide dosing and outcomes in patients newly diagnosed with multiple myeloma: Results from the Canadian Myeloma Research Group Database
por: Mian, Hira, et al.
Publicado: (2022) -
The work of managing multiple myeloma and its implications for treatment-related decision making: a qualitative study of patient and caregiver experiences
por: Pritlove, Cheryl, et al.
Publicado: (2021)